Clinical Immunology Communications

In times of crisis, it is crucial that information is disseminated quickly and accurately to the appropriate channels. In today’s technological world, there is a plethora of misinformation that can negatively sway individuals and provide them with false reports. To ensure information is distributed appropriately, organizations must implement a plan to ensure their communication is effective. Further study on the best practices and challenges of managing crisis and risk communications is required to ensure organizations are prepared. The Research Anthology on Managing Crisis and Risk Communications discusses strategies and tactics to effectively manage communication in times of crisis and considers the difficulties associated with maintaining a clear line of information. The book also provides an overview of the potential future directions for this field to improve communications moving forward. Covering key topics such as misinformation, technology, leadership, and human health, this major reference work is ideal for managers, business owners, organization leaders, industry professionals, government officials, policymakers, researchers, academicians, scholars, practitioners, instructors, and students.

This book gathers selected high-quality research papers presented at the Sixth International Congress on Information and Communication Technology, held at Brunel University, London, on February 25–26, 2021. It discusses emerging topics pertaining to information and communication technology (ICT) for managerial applications, e-governance, e-agriculture, e-education and computing technologies, the Internet of things (IoT) and e-mining. Written by respected experts and researchers working on ICT, the book offers a valuable asset for young researchers involved in advanced studies. The book is presented in four volumes.

Research presented at the 7th International Conference on Disaster Management and Human Health: Reducing Risk, Improving Outcomes is contained in this volume. These contributions from academics and experts focus on public health, security and disaster management with the goal to assess the potential risk from various types of disaster and highlight ways to prevent or alleviate any damage. There is a need for academia and practitioners to exchange knowledge and experience on the way to handle the increasing risk of natural and human-made disasters. Recent major earthquakes, tsunamis, hurricanes, floods and other natural phenomena have resulted in huge losses in terms of human life and property destruction. A new range of human-made disasters have afflicted humanity in modern times; terrorist activities have been added to more classical disasters such as those due to the failure of industrial installations for instance. It is important to understand the nature of these global risks to be able to develop strategies to prepare for these events and plan effective responses in terms of disaster management and the associated human health impacts. The papers included in this volume cover such topics as Disaster analysis; Disaster monitoring and mitigation; Emergency preparedness; Risk mitigation; Security decision making; Community recovery and resilience; Socio-economic issues; Public health risk; Disaster psychology; Human factors; Multi-hazard risk assessment; Crisis and communication; Learning from disasters; Terrorism and man-made disasters; Business and service continuity; Disaster risk reduction (DRR); New technologies and tools for disaster evaluation; Disaster governance policies; Environmental issues; Recovery and restoration; Disaster modelling; Surveillance and remote sensing; Disaster response.

The pace and sophistication of advances in medicine in the past two decades have necessitated a growing need for a comprehensive reference that highlights current issues in medicine. Each volume in the Current Issues in Medicine series is a stand‐alone text that provides a broad survey of various critical topics—all accomplished in a user-friendly yet interconnected format. The series not only highlights current advances but also explores related topics such as translational medicine, regulatory science, neglected diseases, global pandemics, patent law, immunotoxicology, theranostics, big data, artificial intelligence, novel imaging tools, combination drug products, and novel therapies. While bridging the gap between basic research and clinical medicine, this series provides a thorough understanding of medicine’s potential to address health problems from both the patient’s and the provider’s perspectives in a healthcare setting. The range of topics covered and the expertise of the contributing authors accurately reflect the rapidly evolving areas within medicine—from basic medical sciences to clinical specialties. Each volume is essential reading for physicians, medical students, nurses, fellows, residents, undergraduate and graduate students, educators, policymakers, and biomedical researchers. The multidisciplinary approach of the series makes it a valuable reference resource for the pharmaceutical industry, academia, and governments. However, unlike other series on medicine or medical textbooks, this series focuses on current trends, perspectives, and issues in medicine that are central to healthcare delivery in the 21st century. Volume 2 focuses on the current issues in basic medical sciences, subjects that are fundamental to the practice of medicine. Specifically, it discusses clinical immunology, medical microbiology, COVID-19, and big data. These subjects, traditionally taught in the first two years of medical school that precede clinical instruction, provide a core of basic knowledge critical to the success in clinical medicine during rotations, training, and medical practice.

Issues for 1977-1979 include also Special List journals being indexed in cooperation with other institutions. Citations from these journals appear in other MEDLARS bibliographies and in MEDLING, but not in Index medicus.

First multi-year cumulation covers six years: 1965-70.

First multi-year cumulation covers six years: 1965-70.

The healthcare sector has never been under as much pressure as it is today. This pressure has motivated organizations to reinvent themselves, forcing management and marketing to take a more active role. Due to this reinvention, organizations must incorporate a stronger culture of management and marketing orientation that allows companies to define their course, optimize their resources, communicate with their stakeholders more efficiently, and encourage customers to become more involved with the company. This need is particularly urgent in the healthcare sector, as its weight in the economy has grown recently and it must prepare for economic recovery. Management and Marketing for Improved Competitiveness and Performance in the Healthcare Sector provides knowledge and skills to apply management and marketing on strategic, tactical, and operational aspects with an emphasis on the healthcare industry. Various aspects of management and marketing, such as operations management, quality management, human resources, brand management, and digital marketing, are discussed. The book is ideal for management and marketing academics, their students (undergraduate/graduate programs), researchers, managers, advertisers, healthcare organizations, hospital boards, pharmaceutical representatives, and marketers who need to optimize the potential of management marketing applied in the healthcare industry.

Each issue lists papers published during the preceding year.

This volume provides an authoritative and balanced account of current knowledge and practice in the area of clinical nutrition.

In 2003, Congress passed the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, which established a 5-year, $15 billion initiative to help countries around the world respond to their AIDS epidemics. The initiative is generally referred to by the title of the 5-year strategy required by the act--PEPFAR, or the President's Emergency Plan for AIDS Relief. PEPFAR Implementation evaluates this initiative's progress and concludes that although PEPFAR has made a promising start, U.S. leadership is still needed in the effort to respond to the HIV/AIDS pandemic. The book recommends that the program transition from its focus on emergency relief to an emphasis on the long-term strategic planning and capacity building necessary for a sustainable response. PEPFAR Implementation will be of interest to policy makers, health care professionals, special interest groups, and others interested in global AIDS relief.

Covers only the management sector of the executive branch.

This monograph is a comprehensive expose of the disorder vitiligo. The book introduces the topic with a presentation about its cultural effects in the Middle East where vitiligo is exceptionally disabling to the affected person. Nehru as Prime Minister of India stated that vitiligo was a major impediment to the successful development of India. The book includes sections on the definition of vitiligo based on a consensus of world experts on vitiligo. There is a complete description of its clinical manifestations including the extracutaneous sites by world experts. Differentiation of vitiligo from other forms of depigmentation associated with malignancies is included with sufficient photographs to document differences. A section will present the physiological changes associated with depigmentation - a little known phenomena. The complete histology, differential diagnosis and animal models are major sections. The animal models are important in formulating theories about the causes of vitiligo. Most clinicians will find this section very informative. The book finishes with a thorough treatise on the principles of therapy.